Navigation Links
Neurocrine Biosciences to Present at the 35th Annual J.P. Morgan Healthcare Conference
Date:1/3/2017

SAN DIEGO, Jan. 3, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and CEO of Neurocrine Biosciences, will be presenting at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco.

The live presentation takes place on Monday, January 9 at 2:30pm PT (5:30pm ET).  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.  

Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and INGREZZA (valbenazine or NBI-98854), a vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine plans to commercialize INGREZZA in the United States upon approval by the FDA.

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300383511.html


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Neurocrine Biosciences to Present at the 28th Annual Piper Jaffray Healthcare Conference
2. Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference
3. Neurocrine Biosciences Announces the Acceptance of Three Scientific Abstracts for Valbenazine (NBI-98854) at the 68th Annual Meeting of the American Academy of Neurology in Vancouver April 2016
4. Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2015 Results
5. Neurocrine Biosciences to Present at the Leerink Partners 5th Annual Global Healthcare Conference
6. Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome
7. Neurocrine Announces Successful Completion of Phase Ib T-Force Study of VMAT2 Inhibitor NBI-98854 in Adolescents and Children with Tourette Syndrome
8. Neurocrine Biosciences to Present at Credit Suisses 24th Annual Healthcare Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2015 Results
10. Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor NBI-98854 in Adults with Tourette Syndrome
11. Neurocrine Announces Positive Results from Phase III Kinect 3 Study of NBI-98854 in Tardive Dyskinesia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2019)... , ... November 15, 2019 , ... ... living with memory impairment, has announced the Best Memory Care Facilities in Columbus, ... experts, facility features and amenities. , According to the Alzheimer’s Association ...
(Date:11/16/2019)... ... November 15, 2019 , ... October 29 article ... any time when more than usual is being consumed – is best done near ... doing so, the sugars and acids found in candy are more likely to be ...
(Date:11/15/2019)... ... , ... JustCBD looks forward to working with Hope For The ... by the military families aboard Marine Corps Base Camp Lejeune, North Carolina. These families ... the past 13 years, Hope For The Warriors has been dedicated to serving those ...
Breaking Medicine Technology:
(Date:11/15/2019)... N.Y. (PRWEB) , ... November 15, 2019 , ... ... of over 100 employers in Newsday’s Top Long Island Workplaces for 2019. The ... , During the selection process, Newsday worked in partnership with Energage to ...
(Date:11/14/2019)... (PRWEB) , ... November 14, 2019 , ... ... treatments for cancers and other serious diseases, announced it will have 5 poster ... at the upcoming 24th Annual Society for Neuro-Oncology SNO Meeting in Phoenix, beginning ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... individuals/organizations who have truly impacted those diagnosed with infertility. This year, Academy of ... Award for Achievement, presented at the Night of Hope Gala in New York ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... most complete business management solution for physical therapy and rehabilitation operators throughout the ... engagement technology with customers in 102 countries, today announces a joint venture to ...
(Date:11/11/2019)... ... November 11, 2019 , ... Thermal Product Solutions, a ... Gruenberg Depyrogenation Sterilizers to the Pharmaceutical Industry. The units will be used ... 280°C with work chamber dimensions of 36” W x 36” D x 53” ...
Breaking Medicine News(10 mins):